About Sharon Lew
Form D filings for Io Therapeutics in 2023 list Sharon Lew as executive officer.
Sharon Lew first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Sharon Lew in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Sharon Lew works with at each company, as listed on that company's latest Form D.
Io Therapeutics, Inc. · Form D/A, Aug 3, 2023
SC
Sahani Chandraratna
Director
VV
Vidyasagar Vuligonda
Executive officer
MS
Martin Sanders
Chief Executive Officer